Examples of questions

At AIMday Diagnostics & Biomarkers you and your company have the unique opportunity to discuss your specific issues with university specialists in the field.
Here are some examples of question from previous years AIMday meetings within the life science area brought up by companies for discussion.

• How should pathology and molecular diagnosis be developed to achieve the most effective diagnosis, prognosis and follow-up in both routine care and clinical research?
• How can one identify “super responders” amongst breast cancer patients receiving endocrine therapy for advanced breast cancer?
• What new predictive biomarkers are being identified for diabetes and diabetes-related complications?
• How can a radiolabeled synthetic amino acid be used in PET / CT studies for diagnosis, treatment qualification, and monitoring of treatment efficacy in tumor diseases?
• How can academia and industry collaborate around relevant patient materials in order to develop new biomarkers and biomarker assays? What are the ethical and intellectual property issues that need to be taken into account for the use of specific patient material?